Research Progress on Reversion of Mild Cognitive Impairment to Normal Cognition

doi:10.12114/j.issn.1007-9572.2021.00.500

Abstract

Abstract: Mild cognitive impairment（MCI） is generally deemed to be a high-risk population and therapeutic target for Alzheimer's disease（AD）. Although older adults with MCI have a 10%-15% annual risk of converting to probable AD，most MCIs remain stable，and partially reverse to normal cognition （NC）. So far，the significance of the reversion of MCI to NC remains extremely inconclusive and controversial，and systematic research at home and abroad is still limited. This article systematically sorts out the reversal rate of MCI，various reasons and influential factors，and proposes the significance of the reversion of MCI to NC and the problems to be solved.

Key words: Mild cognitive impairment, Alzheimer disease, Reversion, Normal cognition, Review

摘要： 轻度认知障碍（MCI）通常被认为是阿尔茨海默病（AD）的高风险人群和治疗靶点。尽管每年有近10%~15%的MCI患者进展为AD，但MCI的认知轨迹高度可变，多数MCI患者并没有随着时间的推移而进展为AD，部分逆转为认知正常（NC）。迄今为止，关于MCI逆转为NC的意义尚无定论，且国内外MCI逆转为NC的系统研究仍然有限。本文系统梳理了MCI的逆转率、逆转原因、逆转的潜在影响因素及逆转的研究意义，提出了此类研究亟待解决的问题及展望。

关键词: 轻度认知障碍, 阿尔茨海默病, 逆转, 认知正常, 综述

QIN Yao,ZHANG Jiajia,WU Yan, et al. Research Progress on Reversion of Mild Cognitive Impairment to Normal Cognition　[J]. Chinese General Practice, 2021, 24(27): 3506-3509. DOI: 10.12114/j.issn.1007-9572.2021.00.500.
秦瑶,张嘉嘉,吴妍等. 轻度认知障碍逆转为认知正常的研究进展[J]. 中国全科医学, 2021, 24(27): 3506-3509. DOI: 10.12114/j.issn.1007-9572.2021.00.500.

References

［1］MALEK-AHMADI M.Reversion from mild cognitive impairment to normal cognition a meta-analysis ［J］．Alzheimer Dis Assoc Disord，2016，30（4）：324-330．DOI：10.1097/WAD.0000000000000145.
［2］PANDYA S Y，CLEM M A，SILVA L M，et al．Does mild cognitive impairment always lead to dementia? A review［J］．J Neurol Sci，2016，369：57-62．DOI：10.1016/j.jns.2016.07.055.
［3］TOKUCHI R，HISHIKAWA N，KURATA T，et al．Clinical and demographic predictors of mild cognitive impairment for converting to Alzheimer's disease and reverting to normal cognition［J］．J Neurol Sci，2014，346（1/2）：288-292．DOI：10.1016/j.jns.2014.09.012.
［4］GAO Q，GWEE X，FENG L，et al．Mild cognitive impairment reversion and progression：rates and predictors in community-living older persons in the Singapore longitudinal ageing studies cohort［J］．Dement Geriatr Cogn Dis Extra，2018，8（2）：226-237．DOI：10.1159/000488936.
［5］ROBERTS R O，KNOPMAN D S，MIELKE M M，et al．Higher risk of progression to dementia in mild cognitive impairment cases who revert to normal［J］．Neurology，2014，82（4）：317-325．DOI：10.1212/wnl.0000000000000055.
［6］PETERSEN R C.Mild cognitive impairment as a diagnostic entity［J］．J Intern Med，2004，256（3）：183-194．DOI：10.1111/j.1365-2796.2004.01388.x.
［7］XU Y，CHEN K，ZHAO Q，et al．Short-term delayed recall of auditory verbal learning test provides equivalent value to long-term delayed recall in predicting MCI clinical outcomes：a longitudinal follow-up study［J］．Appl Neuropsychol Adult，2020，27（1）：73-81．DOI：10.1080/23279095.2018.1481067.
［8］KOEPSELL T D，MONSELL S E.Reversion from mild cognitive impairment to normal or near-normal cognition：risk factors and prognosis［J］．Neurology，2012，79（15）：1591-1598．DOI：10.1212/wnl.0b013e31826e26b7.
［9］SHIMADA H，MAKIZAKO H，DOI T，et al．Conversion and reversion rates in Japanese older people with mild cognitive impairment［J］．J Am Med Dir Assoc，2017，18（9）：808.e1-6．DOI：10.1016/j.jamda.2017.05.017.
［10］PETERSEN R C，NEGASH S.Mild cognitive impairment：an overview ［J］．CNS Spectr，2008，13（1）：45-53．DOI：10.1017/s1092852900016151.
［11］PANDYA S Y，LACRITZ L H，WEINER M F，et al．Predictors of reversion from mild cognitive impairment to normal cognition［J］．Dement Geriatr Cogn Disord，2017，43（3/4）：204-214．DOI：10.1159/000456070.
［12］XUE H，HOU P，LI Y，et al．Factors for predicting reversion from mild cognitive impairment to normal cognition：a meta-analysis［J］．Int J Geriatr Psychiatry，2019，34（10）：1361-1368．DOI：10.1002/gps.5159.
［13］CANEVELLI M，GRANDE G，LACORTE E，et al．Spontaneous reversion of mild cognitive impairment to normal cognition：a systematic review of literature and meta-analysis［J］．J Am Med Dir Assoc，2016，17（10）：943-948．DOI：10.1016/j.jamda.2016.06.020.
［14］GAO S，UNVERZAGT F W，HALL K S，et al．Mild cognitive impairment，incidence，progression，and reversion：findings from a community-based cohort of elderly African Americans［J］．Am J Geriatr Psychiatry，2014，22（7）：670-681．DOI：10.1016/j.jagp.2013.02.015.
［15］GANGULI M，DODGE H H，SHEN C Y，et al．Mild cognitive impairment，amnestic type：an epidemiologic study［J］．Neurology，2004，63（1）：115-121．DOI：10.1212/01.wnl.0000132523.27540.81.
［16］HAN J W，KIM T H，LEE S B，et al．Predictive validity and diagnostic stability of mild cognitive impairment subtypes［J］．Alzheimers Dement，2012，8（6）：553-559．DOI：10.1016/j.jalz.2011.08.007.
［17］王英全，梁景宏，贾瑞霞，等．2020—2050年中国阿尔茨海默病患病情况预测研究［J］．阿尔茨海默病及相关病，2019，2（1）：289-298.
［18］CHUNG J Y，YOON H J，KIM H，et al．Reversion from mild cognitive impairment to normal cognition：false-positive error or true restoration thanks to cognitive control ability?［J］．Neuropsychiatr Dis Treat，2019，15：3021-3032．DOI：10.2147/ndt.s223958.
［19］NGANDU T，LEHTISALO J，SOLOMON A，et al．A 2 year multidomain intervention of diet，exercise，cognitive training，and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people （FINGER）：a randomised controlled trial［J］．Lancet，2015，385（9984）：2255-2263．DOI：10.1016/s0140-6736（15）60461-5.
［20］PARK M H，HAN C.Is there an MCI reversion to cognitively normal? Analysis of Alzheimer's disease biomarkers profiles ［J］．Int Psychogeriatr，2015，27（3）：429-437．DOI：10.1017/S1041610214002129.
［21］PETERSEN R C.Clinical practice.Mild cognitive impairment ［J］．N Engl J Med，2011，364（23）：2227-2234．DOI：10.1056/NEJMcp0910237.
［22］SACHDEV P S，LIPNICKI D M，CRAWFORD J，et al．Factors predicting reversion from mild cognitive impairment to normal cognitive functioning：a population-based study［J］．PLoS One，2013，8（3）：e59649．DOI：10.1371/journal.pone.0059649.
［23］SALTHOUSE T A.Frequent assessments may obscure cognitive decline［J］．Psychol Assess，2014，26（4）：1063-1069．DOI：10.1037/pas0000007.
［24］MACHULDA M M，PANKRATZ V S，CHRISTIANSON T J，et al．Practice effects and longitudinal cognitive change in normal aging vs.incident mild cognitive impairment and dementia in the Mayo Clinic Study of Aging［J］．Clin Neuropsychol，2013，27（8）：1247-1264．DOI：10.1080/13854046.2013.836567.
［25］BARTELS C，WEGRZYN M，WIEDL A，et al．Practice effects in healthy adults：a longitudinal study on frequent repetitive cognitive testing ［J］．BMC Neurosci，2010，11：118．DOI：10.1186/1471-2202-11-118.
［26］GIFFORD K A，LIU D，LU Z，et al．The source of cognitive complaints predicts diagnostic conversion differentially among nondemented older adults［J］．Alzheimers Dement，2014，10（3）：319-327．DOI：10.1016/j.jalz.2013.02.007.
［27］KANG Y，KIM M，JUNG D，et al．Factors associated with cognition recovery among elders with mild cognitive impairment in Korea ［J］．Int Nurs Rev，2014，61（3）：318-326．DOI：10.1111/inr.12116.
［28］CHOI M，LOHMAN M C，MEZUK B.Trajectories of cognitive decline by driving mobility：evidence from the Health and Retirement Study［J］．Int J Geriatr Psychiatry，2014，29（5）：447-453．DOI：10.1002/gps.4024.
［29］OSONE A，ARAI R，HAKAMADA R，et al．Impact of lifestyle-related disease on conversion and reversion in patients with mild cognitive impairment：after 12 months of follow-up［J］．Int J Geriatr Psychiatry，2016，31（7）：740-748．DOI：10.1002/gps.4386.
［30］GRANDE G，CUCUMO V，COVA I，et al．Reversible mild cognitive impairment：the role of comorbidities at baseline evaluation［J］．J Alzheimers Dis，2016，51（1）：57-67．DOI：10.3233/jad-150786.
［31］SUGARMAN M A，ALOSCO M L，TRIPODIS Y，et al．Neuropsychiatric symptoms and the diagnostic stability of mild cognitive impairment［J］．J Alzheimers Dis，2018，62（4）：1841-1855．DOI：10.3233/jad-170527.
［32］SHIMADA H，DOI T，LEE S，et al．Reversible predictors of reversion from mild cognitive impairment to normal cognition：a 4-year longitudinal study［J］．Alzheimers Res Ther，2019，11（1）：24．DOI：10.1186/s13195-019-0480-5.
［33］VERMUNT L，VAN PAASEN A J L，TEUNISSEN C E，et al．Alzheimer disease biomarkers may aid in the prognosis of MCI cases initially reverted to normal［J］．Neurology，2019，92（23）：e2699-2705．DOI：10.1212/wnl.0000000000007609.
［34］CANEVELLI M，BLASIMME A，VANACORE N，et al．From evidence to action：promoting a multidimensional approach to mild cognitive impairment ［J］．J Am Med Dir Assoc，2015，16（8）：710-711．DOI：10.1016/j.jamda.2015.04.013.
［35］LANGA K M，LEVINE D A.The diagnosis and management of mild cognitive impairment：a clinical review［J］．JAMA，2014，312（23）：2551-2561．DOI：10.1001/jama.2014.13806.
［36］JANG A R，YOON J Y.Factors affecting reversion from mild cognitive impairment to normal cognition in midlife to later life in Korea：a national population study ［J］．Geriatr Gerontol Int，2019，19（11）：1129-1135．DOI：10.1111/ggi.13783.
［37］MORLEY J E.Mild cognitive impairment-a treatable condition［J］．J Am Med Dir Assoc，2014，15（1）：1-5．DOI：10.1016/j.jamda.2013.11.001.

[1]	LIAO Kexin, XIAO Yisheng. Effects of the Compatibility Extract of Huangjing Pill on the Hippocampal DG Region Stem Cells in Rats with Learning and Memory Impairments [J]. Chinese General Practice, 2025, 28(24): 3019-3025.
[2]	WANG Biqing, ZHANG Ping, YANG Hongxia, WANG Qian, JU Chunxiao, ZHAO Junnan, MEI Jun, ZHANG Ying, XU Fengqin. Meta-analysis of Prevalence and Development Trend of Mild Cognitive Impairment in Elderly Hypertensive Patients in China [J]. Chinese General Practice, 2025, 28(17): 2186-2192.
[3]	YUAN Yiqing, CHEN Honglin. Research Progress on Stigma of Cognitive Disorders [J]. Chinese General Practice, 2025, 28(05): 631-638.
[4]	WU Qingyue, CHEN Xiaoling, ZHOU Xunqiong, YANG Jingyuan, ZHOU Quanxiang, YANG Xing. Study on the Relationship between Inter-arm Blood Pressure Difference and Mild Cognitive Impairment in Rural Elderly People [J]. Chinese General Practice, 2024, 27(29): 3616-3622.
[5]	YU Ruxia, JIANG Jing, WANG Qiucheng, WANG Yue, ZHAO Xiaoyue. The Hotspots and Frontier Trends of Artificial Intelligence in the Clinical Diagnosis and Treatment of Alzheimer's Disease: Bibliometric Analysis of the Past 20 Years [J]. Chinese General Practice, 2024, 27(26): 3218-3226.
[6]	WANG Chenyu, ZHANG Chen, SHI Lulu, ZHU Mengna, WANG Lina. Advances in Cognitive Function Health Management Strategies for Individuals with Mild Cognitive Impairment in Community [J]. Chinese General Practice, 2024, 27(26): 3273-3280.
[7]	ZHOU Lulu, LU Yuan, ZHANG Yi, GAO Xin, LIU Fang, CHENG Yuan, FENG Yuqin, YU Dehua. Analysis of Social Support and Related Factors of Family Caregivers of Patients with Mild Cognitive Impairment [J]. Chinese General Practice, 2024, 27(16): 1977-1983.
[8]	MA Jia, ZHANG Minjue, ZHANG Shaowei, YU Haiyan, CHEN Shen, Gulibaier MAMUTI, HONG Juan, LU Yuan. Community Management of Elderly Patients with Type 2 Diabetes Complicated with Mild Cognitive Impairment Related Factors [J]. Chinese General Practice, 2024, 27(16): 1984-1989.
[9]	ZHANG Min, LU Yuan, GAO Song, YU Dehua. Study of the Perceptions of Mild Cognitive Impairement among Community Populations Questionnaire Developed Based on Delphi Method [J]. Chinese General Practice, 2024, 27(16): 1990-1997.
[10]	ZHANG Yong, WANG Senli, HUANG Ronghua, XU Fengping, LIU Dan. Intervention Effect of Music Therapy on Patients with Alzheimers Disease: a Meta-analysis [J]. Chinese General Practice, 2024, 27(12): 1511-1518.
[11]	ZHANG Min, LU Yuan, GAO Song, MA Jia, LIU Yalin, ZHAI Jiayi, YU Dehua. Analysis on the Perceptions Toward Mild Cognitive Impairment and Medical Willingness among Population Aged over 55 Years in Shanghai Based on a Proactive Health Perspective [J]. Chinese General Practice, 2024, 27(10): 1208-1214.
[12]	LI Yaping, LI Xia. Research Progress of Correlation and Underlying Mechanisms between Metabolic Syndrome and Alzheimer's Disease [J]. Chinese General Practice, 2024, 27(03): 268-272.
[13]	FAN Yun, DOU Runpeng, HU Jiulue, HOU Zijun, ZHOU Chunxiang. Modulation of Iron Death by Poric Acid through Nrf2/SLC7A11/GPX4 Signal Pathway in the Improvement of Cognitive Impairment of Alzheimer's Disease Rats [J]. Chinese General Practice, 2024, 27(02): 177-183.
[14]	XIN Gongkai, CONG Xin, YUAN Lei, CHENG Yuetong, NI Cuiping, ZHANG Weiwei, ZHANG Pingping, LIU Yu. Research Progress on Comprehensive Assessment Tools for the Elderly with Dementia [J]. Chinese General Practice, 2023, 26(33): 4103-4109.
[15]	ZHOU Sijing, LUO Bangan, CAO Hui, ZHANG Xi, WANG Dongxin. Epidemiological Characteristics of Dementia and Its Correlation with Multimorbidity among Residents Aged 65 and Above [J]. Chinese General Practice, 2023, 26(29): 3616-3621.